A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...
At UC, 70% of undergrads participate in research, creative projects or service learning. Three new programs bridge classroom ...
A detailed overview of NeuroSalt's five-ingredient plant-based nerve health supplement - covering botanical formula ...
Algoma University’s Great Lakes International Summer Music Experience is turning its Sault Ste. Marie campus into a two-week ...
The Lanier Mansion State Historic Site in Madison is exactly that kind of place, a Greek Revival masterpiece that looks like ...
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...
Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing ...
Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.
New psychoactive substances (NPS) are a class of artificially designed and synthesized chemical substances designed to mimic the pharmacological effects of traditional drugs. They are characterized by ...